insights_auto
Nega MYGN oshdi 2,62%?
Batafsil oʻrganishchevron_right
MYGN:NASDAQ
Myriad Genetics Inc
4,31 US$
arrow_upward
+2,62%(+0,11) 1K
4,31 US$
0,00% (0,00)
bedtimeYopilgandan keyin
Savdolar yopilgan: 9-okt, 16:00:01 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoMYGN tikeri uchun statistika yaratilmoqda...
Ochish
4,18 US$
Yuqori
4,40 US$
Past
4,15 US$
Bozor kapitali
412,25 mln
Oʻrtacha hajm
2,03 mln
Hajmi
1,37 mln
52 haftalik eng yuqori
8,59 US$
52 haftalik eng past
2,74 US$
Aksiya boʻyicha daromad
-1,20 US$
Beta
1,64
Muomaladagi aksiyalar
95,65 mln
Xodimlar soni
3 ming
Ochish
4,18 US$
Yuqori
4,40 US$
Past
4,15 US$
Bozor kapitali
412,25 mln
Oʻrtacha hajm
2,03 mln
Hajmi
1,37 mln
52 haftalik eng yuqori
8,59 US$
52 haftalik eng past
2,74 US$
Aksiya boʻyicha daromad
-1,20 US$
Beta
1,64
Muomaladagi aksiyalar
95,65 mln
Xodimlar soni
3 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Investing.com
·
3 kun oldin
Myriad Genetics, SOPHiA partner on prostate cancer biomarker
Profil
Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a patient's likelihood of responding to a particular drug therapy, assess a patient's risk of disease progression and disease recurrence, and measure disease activity. Wikipedia
Myriad Genetics Inc haqida
CEOPaul J. Diaz | Paul J. Diaz
Xodimlar soni2,7 ming
Asos solingan1991
Bosh ofislarSalt Lake City, Yuta, Amerika Qo‘shma Shtatlari
Sektor-
Veb-saytmyriad.com